NPPES file of Aug 9, 2026

Christopher David Corso, MD

Radiation Oncology Physician · Charlotte, NC

Christopher David Corso, MD is a radiation oncology physician with a practice address in Charlotte, North Carolina, and NPI 1871868026, issued on Mar 20, 2012. Check the license (North Carolina 2017-00143, as entered in NPPES) on the North Carolina Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1871868026
Name
Christopher David Corso
Credential
MD
Primary taxonomy
Radiation Oncology Physician 2085R0001X
License numbers
2017-00143 NC
40633 SC
Self-reported in NPPES; status is on the state search
Practice location
200 Queens RD Ste 400, Charlotte, NC 28204
Phone
(704) 333-7376
Enumerated
Mar 20, 2012
Record last updated
Jul 21, 2022
Medicare enrollment
Enrolled (PECOS I20170711003174); accepts Medicare assignment
Medical or professional school
Emory University School Of Medicine, 2012
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 200 Queens RD Ste 400

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Wilson Brooks, PA-CMedical Physician Assistant1447999339
  2. Taylor Corriher, MDRadiation Oncology Physician1326675273
  3. Justin Hart, M.D.Radiation Oncology Physician1316263353
  4. Michael Lecompte, MDRadiation Oncology Physician1497377139
  5. Kaitlin Lyghtel, FNPNurse Practitioner1205422904
  6. Jahan Mohiuddin, MDRadiation Oncology Physician1093177727

Verify Christopher David Corso in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNorth Carolina Medical Board
    Search for license 2017-00143
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the North Carolina license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

58% more Medicare Part D claims than the average radiation oncology physician in 2024

212 Medicare Part D claims for 113 beneficiaries, against an average of 134 among the 4,851 providers of this specialty who prescribed in Part D. Brand-name drugs were 6% of claims. 25 claims were for opioids.

  1. Christopher Corso212
  2. Specialty average134

Most prescribed

  1. Mometasone Furoate54 claims
  2. Tamsulosin Hcl34 claims
  3. Prednisone16 claims
  4. Oxybutynin Chloride Er13 claims
  5. Morphine Sulfate Er11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The MIPS final score for 2023 (Medicare payment program): 95.4 of 100

The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score84.2
  2. Costnot scored (reweighted)
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $226.73

5 payments; by number, the most common kind was food and beverage; the largest payer was Siemens Medical Solutions USA, Inc. The 3,275 providers of this specialty with any payment received $1,897.85 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Christopher Corso$226.73
  2. Specialty average$1,897.85

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

  1. Piedmont Carolinas Radiation Therapy LLCLancaster, SC
  2. Southeast Radiation Oncology Group, P.A.Charlotte, NC

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Christopher David Corso among 230 radiation oncology physician records in North Carolina

Christopher David Corso, MD is one of 230 radiation oncology physician records with a practice address in North Carolina. 78% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2012, is newer than 77% of them.

  • NPI issued2012 · 77% of these records are older, 20% newer
  • In a Medicare fileYes · 78% of these records are
  • In the CMS Doctors and Clinicians fileYes · 73% of these records are
  • Graduated2012 · median 2003 among the 166 with a school on file
  • Record last updated2022 · 67% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 2085R0001X and a North Carolina practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Radiation Oncology Physician providers in North Carolina

There are 230 radiation oncology physician records in North Carolina.

The 8 radiation oncology physician records with the nearest ZIP codes

  1. Stuart Burri, M.D.Charlotte, NC 282041508825506
  2. Robert Fraser, M.D.Charlotte, NC 282041376502534
  3. Donna Girard, M.D.Charlotte, NC 282041194784793
  4. Michael Haake, M.D.Charlotte, NC 282041760441703
  5. John Heinzerling, M.D.Charlotte, NC 282041306045752
  6. Mark Kirsch, M.D.Charlotte, NC 282041225007784
  7. Bradley McCall, M.D.Charlotte, NC 282041316906381
  8. Lamar McGinnis, M.D.Charlotte, NC 282041639138688

Common questions

What is Christopher David Corso, MD's NPI number?

Christopher David Corso, MD's National Provider Identifier (NPI) is 1871868026, issued on Mar 20, 2012. An NPI identifies a provider in billing; it is not a license.

Where is Christopher David Corso, MD located?

The NPPES record lists a practice address at 200 Queens RD Ste 400, Charlotte, NC, 28204. Phone: (704) 333-7376. Providers update this record themselves, so call before visiting.

How can I verify Christopher David Corso, MD's license?

NPPES lists North Carolina license number 2017-00143, as entered by the provider. Search the North Carolina Medical Board at https://portal.ncmedboard.org/verification/search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Christopher David Corso, MD prescribe under Medicare Part D?

In 2024, Christopher David Corso, MD had 212 Medicare Part D claims for 113 beneficiaries; the average among radiation oncology physician prescribers was 134. Part D covers Medicare prescriptions only.

What is Christopher David Corso, MD's MIPS final score?

The 2023 MIPS final score is 95.4 of 100. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.